• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与炎症相关的特征可预测肾透明细胞癌患者的预后。

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma.

作者信息

Yu Qingxin, Zhang Facai, Feng Dechao, Li Dengxiong, Xia Yuhui, Gan Mei-Fu

机构信息

Department of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, China.

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Genet. 2022 Aug 11;13:866696. doi: 10.3389/fgene.2022.866696. eCollection 2022.

DOI:10.3389/fgene.2022.866696
PMID:36035192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9405188/
Abstract

Kidney renal clear cell carcinoma (KIRC) is an inflammation-related carcinoma, and inflammation has been recognized as an important factor in inducing carcinogenesis. To further explore the role of inflammation in KIRC, we developed an inflammation-related signature and verified its correlation with the tumor micro-environment. After the differential inflammation-related prognostic genes were screened by Lasso regression, the inflammation-related signature (IRS) was constructed based on the risk score of multivariate Cox regression. Then, the prognostic value of the IRS was evaluated by Kaplan-Meier analysis, receiver operating characteristic (ROC) curve analysis and multivariate Cox regression. Gene set variation analysis (GSVA) was applied to screen out enriched signaling pathways. Infiltrated immune cells, tumor mutational burden (TMB) and immune checkpoints were explored by CIBERSORTx and maftool. Four genes (TIMP1, PLAUR, CCL22, and IL15RA) were used to construct the IRS in patients with KIRC. Kaplan-Meier analysis and multivariate Cox regression identified that the IRS could independently predict the prognosis of patients with KIRC in the training and validation groups. The diagnostic value of the nomogram increased from 0.811 to 0.845 after adding the IRS to the multiparameter ROC analysis. The GSVA results indicated that IRS was closely related to primary immunodeficiency and antigen processing and presentation. The immune checkpoint LAG3 was highly expressed in patients with high-risk score ( < 0.05), while CD274 (PD-L1) and HAVCR2 were highly expressed in patients with low-risk score ( < 0.001). There was a significant positive correlation between the high-risk score group and CD8 T, activated CD4 memory T, gamma and delta regulatory T and M0 macrophage cells, while the low-risk score group was negatively associated with B memory, plasma, resting CD4 memory T, activated NK, M1 macrophages and resting mast cells. We found that the IRS might serve as a biomarker to predict the survival of KIRC. Moreover, patients with high or low-risk score might be sensitive to immune drugs at different immune checkpoints.

摘要

肾透明细胞癌(KIRC)是一种与炎症相关的癌症,炎症已被认为是诱导癌变的重要因素。为了进一步探究炎症在KIRC中的作用,我们开发了一种与炎症相关的特征,并验证了其与肿瘤微环境的相关性。通过Lasso回归筛选出差异炎症相关预后基因后,基于多变量Cox回归的风险评分构建了炎症相关特征(IRS)。然后,通过Kaplan-Meier分析、受试者工作特征(ROC)曲线分析和多变量Cox回归评估IRS的预后价值。应用基因集变异分析(GSVA)筛选出富集的信号通路。通过CIBERSORTx和maftool探索浸润免疫细胞、肿瘤突变负担(TMB)和免疫检查点。使用四个基因(TIMP1、PLAUR、CCL22和IL15RA)构建KIRC患者的IRS。Kaplan-Meier分析和多变量Cox回归表明,IRS可以在训练组和验证组中独立预测KIRC患者的预后。在多参数ROC分析中加入IRS后,列线图的诊断价值从0.811提高到0.845。GSVA结果表明,IRS与原发性免疫缺陷以及抗原加工和呈递密切相关。免疫检查点LAG3在高风险评分患者中高表达(<0.05),而CD274(PD-L1)和HAVCR2在低风险评分患者中高表达(<0.001)。高风险评分组与CD8 T细胞、活化的CD4记忆T细胞、γδ调节性T细胞和M0巨噬细胞之间存在显著正相关,而低风险评分组与B记忆细胞、浆细胞、静息CD4记忆T细胞、活化的NK细胞、M1巨噬细胞和静息肥大细胞呈负相关。我们发现,IRS可能作为预测KIRC患者生存的生物标志物。此外,高风险或低风险评分的患者可能对不同免疫检查点的免疫药物敏感。

相似文献

1
An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma.一种与炎症相关的特征可预测肾透明细胞癌患者的预后。
Front Genet. 2022 Aug 11;13:866696. doi: 10.3389/fgene.2022.866696. eCollection 2022.
2
A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.一种用于预测肾透明细胞癌预后的新型三联基序家族基因特征及其与免疫细胞浸润的关联
Front Oncol. 2022 Mar 17;12:840410. doi: 10.3389/fonc.2022.840410. eCollection 2022.
3
The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.血管生成相关 lncRNAs 在肾透明细胞癌中的临床意义、免疫浸润和肿瘤突变负担。
Front Immunol. 2022 Jul 26;13:934387. doi: 10.3389/fimmu.2022.934387. eCollection 2022.
4
Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.铜死亡相关基因FDX1作为肾透明细胞癌的预后生物标志物,与免疫检查点和免疫细胞浸润相关。
Front Genet. 2023 Jan 23;14:1071694. doi: 10.3389/fgene.2023.1071694. eCollection 2023.
5
GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.GRAMD1A 是肾透明细胞癌的生物标志物,与肿瘤微环境中的免疫浸润有关。
Dis Markers. 2022 Jul 11;2022:5939021. doi: 10.1155/2022/5939021. eCollection 2022.
6
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.构建并验证自噬相关长非编码 RNA 标志物用于预测肾透明细胞癌患者的预后
Cancer Med. 2021 Apr;10(7):2359-2369. doi: 10.1002/cam4.3820. Epub 2021 Mar 2.
7
Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma.一种新型的与失巢凋亡相关的基因特征在透明细胞肾细胞癌中的开发与验证
Front Oncol. 2023 Oct 26;13:1211103. doi: 10.3389/fonc.2023.1211103. eCollection 2023.
8
A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.一种新型的与m7G相关的微小RNA风险特征预测肾透明细胞癌的预后和肿瘤微环境。
Front Genet. 2022 Jun 24;13:922358. doi: 10.3389/fgene.2022.922358. eCollection 2022.
9
Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.基于 TME 相关 lncRNAs 的计算构建用于预测透明细胞肾细胞癌的预后和免疫治疗反应的标志物。
J Clin Lab Anal. 2022 Aug;36(8):e24582. doi: 10.1002/jcla.24582. Epub 2022 Jul 8.
10
Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.预测肾透明细胞癌预后的染色质调节因子相关lncRNA特征及其与免疫微环境的关系:一项基于生物信息学和实验验证的研究
Front Genet. 2022 Oct 20;13:974726. doi: 10.3389/fgene.2022.974726. eCollection 2022.

引用本文的文献

1
Exploring the prognostic role and expression patterns of FAM3A family genes in kidney renal clear cell carcinoma.探索FAM3A家族基因在肾透明细胞癌中的预后作用及表达模式。
Sci Rep. 2025 Jul 1;15(1):22397. doi: 10.1038/s41598-025-05658-x.
2
Targeting ferroptosis for the treatment of female reproductive system disorders.靶向铁死亡用于治疗女性生殖系统疾病。
J Mol Med (Berl). 2025 Apr;103(4):381-402. doi: 10.1007/s00109-025-02528-x. Epub 2025 Mar 18.
3
Unraveling Alzheimer's disease: insights from single-cell sequencing and spatial transcriptomic.

本文引用的文献

1
Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma.VHL 基因转染的生物统计学在肾癌健康信息学分析中的应用。
Comput Math Methods Med. 2022 Jan 7;2022:5297580. doi: 10.1155/2022/5297580. eCollection 2022.
2
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
3
Cancer statistics, 2022.癌症统计数据,2022 年。
解析阿尔茨海默病:来自单细胞测序和空间转录组学的见解
Front Neurol. 2024 Dec 17;15:1515981. doi: 10.3389/fneur.2024.1515981. eCollection 2024.
4
Exploring the role of ADAMTSL2 across multiple cancer types: A pan-cancer analysis and validated in colorectal cancer.探索ADAMTSL2在多种癌症类型中的作用:一项泛癌分析并在结直肠癌中得到验证。
Discov Oncol. 2024 Oct 9;15(1):538. doi: 10.1007/s12672-024-01401-6.
5
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways.肿瘤浸润细胞在推动治疗抵抗途径中的复杂相互作用。
Cell Commun Signal. 2024 Aug 19;22(1):405. doi: 10.1186/s12964-024-01776-7.
6
Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions.肿瘤微环境的时间生物学:对治疗策略和基于昼夜节律的干预措施的启示
Aging Dis. 2024 Mar 27;16(2):645-657. doi: 10.14336/AD.2024.0327.
7
Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma.透明细胞肾细胞癌中与基于免疫检查点抑制剂治疗反应相关的炎症和免疫基因表达模式及机器学习方法
Cancers (Basel). 2023 Nov 29;15(23):5637. doi: 10.3390/cancers15235637.
8
Adhesion-regulating molecule 1 (ADRM1) can be a potential biomarker and target for bladder cancer.黏附调节分子 1(ADRM1)可以作为膀胱癌的一个潜在的生物标志物和治疗靶点。
Sci Rep. 2023 Sep 8;13(1):14803. doi: 10.1038/s41598-023-41992-8.
9
A novel endothelial-related prognostic index by integrating single-cell and bulk RNA sequencing data for patients with kidney renal clear cell carcinoma.通过整合肾透明细胞癌患者的单细胞和批量RNA测序数据构建的一种新型内皮相关预后指数。
Front Genet. 2023 Mar 10;14:1096491. doi: 10.3389/fgene.2023.1096491. eCollection 2023.
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Inflammation-Related Long Non-Coding RNA Signature Predicts the Prognosis of Gastric Carcinoma.炎症相关长链非编码RNA特征预测胃癌预后
Front Genet. 2021 Nov 8;12:736766. doi: 10.3389/fgene.2021.736766. eCollection 2021.
5
CCR4 as a Therapeutic Target for Cancer Immunotherapy.CCR4作为癌症免疫治疗的一个治疗靶点。
Cancers (Basel). 2021 Nov 4;13(21):5542. doi: 10.3390/cancers13215542.
6
Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.识别和验证透明细胞肾细胞癌患者中与缺氧相关的预后特征。
Medicine (Baltimore). 2021 Oct 1;100(39):e27374. doi: 10.1097/MD.0000000000027374.
7
PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.PLAUR作为与膀胱尿路上皮癌免疫浸润相关的潜在生物标志物。
J Inflamm Res. 2021 Sep 15;14:4629-4641. doi: 10.2147/JIR.S326559. eCollection 2021.
8
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm.IL15RA和SMAD3基因变异预测接受FOLFIRI治疗的转移性结直肠癌患者的总生存期:一种新范式。
Cancers (Basel). 2021 Apr 3;13(7):1705. doi: 10.3390/cancers13071705.
9
Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects.炎症相关致癌作用:从动物模型到临床层面的经验教训
Cancers (Basel). 2021 Feb 22;13(4):921. doi: 10.3390/cancers13040921.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.